10-K: Health Catalyst, Inc. Files 10-K Report, Details Financial Performance and Strategic Initiatives for 2023
Annual Results
Health Catalyst, Inc. released its 2023 10-K filing, outlining its financial results, strategic initiatives, and risk factors.
Summary
- Health Catalyst, Inc., a provider of data and analytics technology and services to healthcare organizations, reported a total revenue of $295.9 million for the year ended December 31, 2023, compared to $276.2 million in 2022.
- The company experienced a net loss of $118.1 million in 2023, an improvement from the $137.4 million loss in 2022.
- Adjusted EBITDA for 2023 was $11.0 million, a significant increase from the negative $2.5 million in 2022.
- The company's revenue is primarily recurring, with over 90% of total revenue coming from subscriptions and professional services.
- As of December 31, 2023, Health Catalyst served 109 DOS Subscription Clients and over 525 other clients.
- The company's Dollar-based Retention Rate for DOS Subscription Clients was 100% for 2023, consistent with 2022, but down from 112% in 2021.
- Health Catalyst is focused on expanding its client base, deepening relationships with existing clients, and adding new analytics applications and services.
- The company is also selectively pursuing acquisitions and partnerships to grow its addressable market.
Sentiment
Score: 7
Explanation: The document shows positive trends in revenue growth and improved profitability, but also highlights significant risks and challenges. The company is making progress, but still has work to do.
Positives
- The company's recurring revenue model provides a high degree of revenue visibility.
- Health Catalyst has a unique and differentiated culture focused on team member engagement.
- The company is recognized as an industry leader by multiple third parties.
- The company has a tenured management team with healthcare technology experience.
- Health Catalyst has a track record of identifying and integrating new and complementary capabilities through acquisitions.
- The company has an attractive operating model due to the scalability of its DOS platform and analytics applications.
Negatives
- The company experienced a net loss of $118.1 million in 2023.
- The company's sales cycles can be long and unpredictable.
- The company faces intense competition from various types of companies.
- The company's results of operations have fluctuated and may continue to fluctuate significantly.
- The company's pricing may change over time and affect its ability to attract or retain clients.
- The company's solution may not operate properly, which could damage its reputation.
Risks
- The company operates in a highly competitive industry, and if it is not able to compete effectively, its business and results of operations will be harmed.
- The company may be unable to successfully execute on its growth initiatives, business strategies, or operating plans, as well as cost reduction and restructuring initiatives.
- Macroeconomic challenges and any new public health crisis could harm the company's business, results of operations, and financial condition.
- Failure by the company's clients to obtain proper permissions and waivers may result in claims against the company or may limit or prevent its use of data, which could harm its business.
- The company's business and operations may suffer in the event of information technology system failures, cyberattacks, or deficiencies in its cybersecurity.
- The company's solution is dependent on its ability to source data from third parties, and such third parties could take steps to block its access to data, or increase fees or impose fees for such access, which could impair its ability to provide its solution.
- The company relies on third-party providers, including Microsoft Azure, for computing infrastructure, network connectivity, and other technology-related services needed to deliver its solution.
Future Outlook
The company expects to continue to grow its client base, expand within its current client base, add new analytics applications and services offerings, and grow its addressable market through additional healthcare business segment adjacencies. The company also plans to selectively pursue acquisitions and partnerships.
Management Comments
- Team member engagement is foundational to everything we do and is the #1 priority of our CEO and broader leadership team.
- We consistently focus on our operating principles and cultural attributes, as well as our mission and Flywheel (collectively, the Health Catalyst Way), which we review in all new hire orientations, company-wide meetings, and board of directors meetings.
Industry Context
The healthcare industry is characterized by waste, changing economics, and data complexity. Organizations that leverage analytics to make data-informed decisions will be better positioned to succeed in this environment. Health Catalyst aims to be a catalyst for massive, measurable, data-informed healthcare improvement.
Comparison to Industry Standards
- Health Catalyst competes with industry-agnostic analytics companies like IBM, Snowflake, and Microsoft, as well as EHR companies like Cerner and Epic Systems.
- The company also competes with point solution vendors such as Optum Analytics, Premier, and Arcadia.io.
- Health Catalyst's focus on a healthcare-specific, open, flexible, and scalable data platform differentiates it from many of its competitors.
- The company's integrated and comprehensive solution, which combines data, analytics, and services expertise, is also a key differentiator.
- Health Catalyst's high team member engagement scores, as measured by Gallup, are a testament to its unique and differentiated culture.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Operating Officer and Chief Product Officer | Anne Marie Bickmore | December 1, 2023 | Separation from employment |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Non-Employee Director Compensation Policy | The company adopted a new Non-Employee Director Compensation Policy, effective as of the Annual Meeting of Stockholders of the Company in June, 2024. | June 2024 | The policy provides a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors who are not employees or officers of the Company or its subsidiaries. |
| Policy for Recovery of Erroneously Awarded Compensation | The company adopted a new Policy for Recovery of Erroneously Awarded Compensation, effective as of October 2, 2023. | October 2, 2023 | The policy provides for the recovery of erroneously awarded incentive-based compensation from current and former officers in the event of a restatement. |
Legal Proceedings
- The company was party to a legal proceeding with Pascal Metrics, Inc., which was settled in June 2023 for $18.8 million without admission of any wrongdoing.
Related Party Transactions
- The company recognized revenue from a related party, Carle Health, of $8.1 million during the year ended December 31, 2023.
Stakeholder Impact
- The company's focus on team member engagement is intended to benefit employees, clients, and other stakeholders.
- The company's commitment to innovation and improvement is intended to benefit clients and the healthcare industry as a whole.
- The company's financial performance impacts shareholders and investors.
Next Steps
- The company plans to continue to invest in research and development, particularly at the analytics applications layer of its technology stack.
- Health Catalyst will continue to emphasize the Health Catalyst Way, including its operating principles and cultural attributes.
- The company will continue to evaluate and identify opportunities where it can leverage its DOS platform to scale and consolidate both data assets and best-of-breed applications.
Key Dates
| Date | Description |
|---|---|
| September 2011 | Health Catalyst, Inc. was incorporated under the laws of Delaware. |
| July 2019 | Health Catalyst completed its initial public offering of shares of its common stock. |
| April 14, 2020 | Health Catalyst issued $230.0 million in aggregate principal amount of 2.50% Convertible Senior Notes due 2025. |
| August 2, 2022 | Health Catalyst's board of directors authorized a share repurchase program. |
| October 2, 2023 | Health Catalyst acquired Electronic Registry Systems, Inc. |
| February 2024 | Health Catalyst will hold its annual Healthcare Analytics Summit (HAS). |
Keywords
healthcare analytics, data platform, cloud-based, software applications, professional services, healthcare providers, data-informed, measurable improvement, DOS platform, subscription model
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.